Abstract
In this prospective observational study, we examined the prescription of anti-anginal drugs preoperatively compared to at one year after operation and the extent to which medically managed secondary prevention measures, including control of hypertension and hyperlipidaemia, were achieved in this patient group.
| Original language | English |
|---|---|
| Journal | Journal of Human Hypertension |
| DOIs | |
| Publication status | Published - 1 Oct 2002 |
Fingerprint
Keywords
- coronary
- hypertension
- surgery
Cite this
}
Are we negating the benefits of CABG by forgetting secondary prevention? / Belcher, P. R.; Gaw, A.; Cooper, M.; Brown, M.; Wheatley, D. J.; Lindsay, Grace M.
In: Journal of Human Hypertension, 01.10.2002.Research output: Contribution to journal › Article
TY - JOUR
T1 - Are we negating the benefits of CABG by forgetting secondary prevention?
AU - Belcher, P. R.
AU - Gaw, A.
AU - Cooper, M.
AU - Brown, M.
AU - Wheatley, D. J.
AU - Lindsay, Grace M.
N1 - Originally published in: Journal of Human Hypertension (2002), 16 (10), pp.691-697.
PY - 2002/10/1
Y1 - 2002/10/1
N2 - In this prospective observational study, we examined the prescription of anti-anginal drugs preoperatively compared to at one year after operation and the extent to which medically managed secondary prevention measures, including control of hypertension and hyperlipidaemia, were achieved in this patient group.
AB - In this prospective observational study, we examined the prescription of anti-anginal drugs preoperatively compared to at one year after operation and the extent to which medically managed secondary prevention measures, including control of hypertension and hyperlipidaemia, were achieved in this patient group.
KW - coronary
KW - hypertension
KW - surgery
U2 - 10.1038/sj.jhh.1001469
DO - 10.1038/sj.jhh.1001469
M3 - Article
ER -